A variety of tumor entities, such as melanoma, ovarian, and lung cancer have been shown to express high levels of the PD ligand 1 (PD-L1) [24,25,26], and it is also expressed on myeloid cells of the tumor microenvironment [27]. This evidence concerns the gene CD274 and lung carcinoma.